Informace o zaměstnanci

doc. PharmDr. Petr Pávek, Ph.D.

email: pavek@faf.cuni.cz,
web:
telefon: +420 495067334, +420 495514373

Curriculum Vitae:

Publikační činnost:
Nejnovějších 5 publikací podle Web of Science:

Hofman J et al. Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone. PHARMACOLOGICAL RESEARCH (IF = 4,436) 2012.

Krausova L et al. Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene. BIOCHEMICAL PHARMACOLOGY (IF = 4,705) 2012.

Novotna A, Doricakova A, Vrzal R, Pavek P, Dvorak Z. Construction and characterization of hepatocyte nuclear factor HNF4alpha1 over-expressing cell line derived from human hepatoma HepG2 cells. EUROPEAN JOURNAL OF PHARMACOLOGY (IF = 2,516) 2011.

Stejskalova L et al. Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Nuclear Translocator Expression in Human and Rat Placentas and Transcription Activity in Human Trophoblast Cultures. TOXICOLOGICAL SCIENCES (IF = 4,652) 2011.

Stejskalova L, Pavek P. The Function of Cytochrome P450 1A1 Enzyme (CYP1A1) and Aryl Hydrocarbon Receptor (AhR) in the Placenta. CURRENT PHARMACEUTICAL BIOTECHNOLOGY (IF = 2,805) 2011.
Pedagogické aktivity:

Vyučované předměty:

Výzkumné aktivity: